Hybridoma technology a versatile method for isolation of monoclonal antibodies, its applicability across species, limitations, advancement and future perspectives HA Parray, S Shukla, S Samal, T Shrivastava, S Ahmed, C Sharma, ... International immunopharmacology 85, 106639, 2020 | 200 | 2020 |
Phage display antibody libraries: A robust approach for generation of recombinant human monoclonal antibodies R Kumar, HA Parray, T Shrivastava, S Sinha, K Luthra International journal of biological macromolecules 135, 907-918, 2019 | 97 | 2019 |
Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B. 1.617. 2) variant surge in India: a test-negative, case-control study and a … R Thiruvengadam, A Awasthi, G Medigeshi, S Bhattacharya, S Mani, ... The Lancet Infectious Diseases 22 (4), 473-482, 2022 | 94 | 2022 |
Inhalation monoclonal antibody therapy: a new way to treat and manage respiratory infections HA Parray, S Shukla, R Perween, R Khatri, T Shrivastava, V Singh, ... Applied microbiology and biotechnology 105, 6315-6332, 2021 | 62 | 2021 |
Identification of an anti–SARS–CoV-2 receptor-binding domain–directed human monoclonal antibody from a naïve semisynthetic library HA Parray, AK Chiranjivi, S Asthana, N Yadav, T Shrivastava, S Mani, ... Journal of Biological Chemistry 295 (36), 12814-12821, 2020 | 59 | 2020 |
A novel G-quadruplex aptamer-based spike trimeric antigen test for the detection of SARS-CoV-2 A Gupta, A Anand, N Jain, S Goswami, A Anantharaj, S Patil, R Singh, ... Molecular Therapy-Nucleic Acids 26, 321-332, 2021 | 56 | 2021 |
Golden Syrian hamster as a model to study cardiovascular complications associated with SARS-CoV-2 infection ZA Rizvi, R Dalal, S Sadhu, A Binayke, J Dandotiya, Y Kumar, ... Elife 11, e73522, 2022 | 52 | 2022 |
Structural basis of Ets1 activation by Runx1 T Shrivastava, K Mino, ND Babayeva, OI Baranovskaya, A Rizzino, ... Leukemia 28 (10), 2040-2048, 2014 | 49 | 2014 |
Inactivated whole-virion vaccine BBV152/Covaxin elicits robust cellular immune memory to SARS-CoV-2 and variants of concern R Vikkurthi, A Ansari, AR Pai, SN Jha, S Sachan, S Pandit, B Nikam, ... Nature Microbiology 7 (7), 974-985, 2022 | 44 | 2022 |
Mechanistic insights from the crystal structures of a feast/famine regulatory protein from Mycobacterium tuberculosis H37Rv T Shrivastava, R Ramachandran Nucleic acids research 35 (21), 7324-7335, 2007 | 42 | 2007 |
Development of a fast SARS-CoV-2 IgG ELISA, based on receptor-binding domain, and its comparative evaluation using temporally segregated samples from RT-PCR positive individuals F Mehdi, S Chattopadhyay, R Thiruvengadam, S Yadav, M Kumar, ... Frontiers in microbiology 11, 618097, 2021 | 36 | 2021 |
Conformational epitope-specific broadly neutralizing plasma antibodies obtained from an HIV-1 clade C-infected elite neutralizer mediate autologous virus escape through … S Patil, R Kumar, S Deshpande, S Samal, T Shrivastava, S Boliar, ... Journal of virology 90 (7), 3446-3457, 2016 | 31 | 2016 |
Antibody-based therapeutic interventions: possible strategy to counter chikungunya viral infection R Kumar, T Shrivastava, S Samal, S Ahmed, HA Parray Applied microbiology and biotechnology 104, 3209-3228, 2020 | 30 | 2020 |
Comparative evaluation of SARS-CoV-2 IgG assays in India S Chaudhuri, R Thiruvengadam, S Chattopadhyay, F Mehdi, P Kshetrapal, ... Journal of Clinical Virology 131, 104609, 2020 | 27 | 2020 |
Longitudinal serology of SARS-CoV-2-infected individuals in India: a prospective cohort study R Thiruvengadam, S Chattopadhyay, F Mehdi, BK Desiraju, S Chaudhuri, ... The American Journal of Tropical Medicine and Hygiene 105 (1), 66, 2021 | 24 | 2021 |
Comparative immunomodulatory evaluation of the receptor binding domain of the SARS-CoV-2 spike protein; a potential vaccine candidate which imparts potent humoral and Th1 type … T Shrivastava, B Singh, ZA Rizvi, R Verma, S Goswami, P Vishwakarma, ... Frontiers in Immunology 12, 641447, 2021 | 24 | 2021 |
Ligand-induced structural transitions, mutational analysis, and ‘open’quaternary structure of the M. tuberculosis feast/famine regulatory protein (Rv3291c) T Shrivastava, A Dey, R Ramachandran Journal of molecular biology 392 (4), 1007-1019, 2009 | 19 | 2009 |
Non-neutralizing SARS CoV-2 directed polyclonal antibodies demonstrate cross-reactivity with the HA glycans of influenza virus P Murugavelu, R Perween, T Shrivastava, V Singh, HA Parray, S Singh, ... International Immunopharmacology 99, 108020, 2021 | 17 | 2021 |
Severe acute respiratory syndrome coronavirus 2 spike protein based novel epitopes induce potent immune responses in vivo and inhibit viral replication in vitro P Vishwakarma, N Yadav, ZA Rizvi, NA Khan, AK Chiranjivi, S Mani, ... Frontiers in immunology 12, 613045, 2021 | 17 | 2021 |
Stabilization of a soluble, native-like trimeric form of an efficiently cleaved Indian HIV-1 clade C envelope glycoprotein S Ahmed, T Shrivastava, N Kumar, G Ozorowski, AB Ward, ... Journal of Biological Chemistry 292 (20), 8236-8243, 2017 | 16 | 2017 |